| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/12/2007 | CA2623813A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | CA2622935A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 04/11/2007 | EP1772518A2 Mammalian-type glycosylation in plants |
| 04/11/2007 | EP1772517A2 DSP-3 dual specificity phosphatase |
| 04/11/2007 | EP1772514A2 Manipulation of tissue or organ type using the notch pathway |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1772462A2 Steroid sulfamates, method for the production and use thereof |
| 04/11/2007 | EP1772454A1 Nitrogenous fused bicyclic compound |
| 04/11/2007 | EP1772150A1 Benzothiophene formulations of a specific dosage |
| 04/11/2007 | EP1772143A1 Peroxisome proliferator-activated receptor (ppar) activator and drugs, supplements, functional foods and food additives using the same |
| 04/11/2007 | EP1771194A2 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 04/11/2007 | EP1771181A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1490093A4 Methods and compositions for the treatment of ischemia |
| 04/11/2007 | EP1480972B1 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 04/11/2007 | EP1439164B1 Novel phenylethanolamine compounds having beta2-acceptor excitatory function and their preparation method |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 04/11/2007 | EP1280416B1 Pet food composition for reducing inflammatory response in cats |
| 04/11/2007 | EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents |
| 04/11/2007 | EP1123094B1 Therapeutic compositions (ii) |
| 04/11/2007 | EP1054894B1 Breast cancer resistance protein (bcrp) and the dna which encodes it |
| 04/11/2007 | EP1019044B1 Composition and methods for treating alzheimer's disease and other amyloidoses |
| 04/11/2007 | EP1015439B1 Prenyl transferase inhibitors |
| 04/11/2007 | EP1012191B1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0984987B1 A soluble laminin receptor precursor and methods to ihnibit its interactions |
| 04/11/2007 | CN1946717A Benzimidazole derivative and its use |
| 04/11/2007 | CN1946712A Pyrrolidine derivative |
| 04/11/2007 | CN1943752A A Medicine for treatment of netting addiction |
| 04/11/2007 | CN1943681A A Chinese traditional medicinal composition for treatment of child feeblemindedness and its preparation method |
| 04/11/2007 | CN1943678A A Chinese traditional medicinal composition for treating geriatric disease and its preparation method |
| 04/11/2007 | CN1943653A An external latex membrane curing mouse hand and its preparation method |
| 04/11/2007 | CN1943634A Consumptive Cattle and fattening composition and its feeding method |
| 04/11/2007 | CN1943605A Process for preparing hypericum japonicum extract |
| 04/11/2007 | CN1943603A Preparation for treating thirsty after nasopharyngeal carcinoma radiotherapy |
| 04/11/2007 | CN1943589A Injection for positioning and promoting fat growth and its preparing method |
| 04/11/2007 | CN1943573A Use of vitamin C and arginine composition in anti-anoxic medicine and health product |
| 04/11/2007 | CN1943332A Method for producing super fine silk yarn |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309818C Technique for preparing mead |
| 04/11/2007 | CN1309763C High-molecular weight derivatives of camptothecins |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309733C Pepties from the 16/6id antibody for treating SLE |
| 04/11/2007 | CN1309720C Piperazine compounds |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309703C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/11/2007 | CN1309392C Hyaluronic acid mediated adenoviral transduction |
| 04/11/2007 | CN1309385C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 04/11/2007 | CN1309381C Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 04/11/2007 | CN1309370C Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 04/11/2007 | CN1309310C Method for increasing pet activity |
| 04/10/2007 | US7202395 Assessment method |
| 04/10/2007 | US7202394 Animal with the mass expression of human gene and test method by using the animal |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202347 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202277 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 04/10/2007 | US7202274 Cyclic hemiacetal derivative and use thereof |
| 04/10/2007 | US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/10/2007 | US7202211 Methods of preventing or treating brain ischemia or brain injury |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7202053 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein |
| 04/10/2007 | US7202052 Regulatory protein for use in induction of nicotinamide adenine dinucleotide oxidase (NOX) for use as free radical quencher in prevention and treatment of cardiovascular and cell proliferative disorders |
| 04/10/2007 | US7202040 Method for screening compounds which change the binding properties of a protein with a ligand |
| 04/10/2007 | US7201913 Oral formulations for anti-tumor compounds |
| 04/10/2007 | US7201895 High-affinity antagonists of ELR-CXC chemokines |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2406783C Skin whiteners containing hydroxytetronic acid |
| 04/10/2007 | CA2389896C Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2377746C N-pyrazole a2a receptor agonists |
| 04/10/2007 | CA2364199C Novel bicyclic derivatives of aminopyrazinone, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2362931C Novel sulforhamnosylacylglycerol derivatives and use thereof as medicaments |
| 04/10/2007 | CA2336380C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 04/10/2007 | CA2333985C Testosterone derivative |
| 04/10/2007 | CA2321969C Process for the production of encased, spherical granular grains |
| 04/10/2007 | CA2269807C Substituted aminoalkanephosphonic acids |
| 04/10/2007 | CA2227977C Use in a composition of an extract of at least one labiate |
| 04/10/2007 | CA2222068C Chimeric fatty body-pro-grf analogs with increased biological potency |
| 04/10/2007 | CA2202170C Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 04/10/2007 | CA2191746C [a]-annelated pyrrole derivatives and pharmaceutical use thereof |
| 04/10/2007 | CA2177772C Pharmaceutical compositions containing irbesartan |
| 04/10/2007 | CA2171289C Il8 inhibitors |
| 04/10/2007 | CA2162306C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha. lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 04/10/2007 | CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation |
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/10/2007 | CA2127084C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-ht1a-antagonistic activity |
| 04/05/2007 | WO2007037543A1 Biarylamide derivative |
| 04/05/2007 | WO2007037534A1 2-heteroaryl-substituted indole derivative |
| 04/05/2007 | WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | WO2007037473A1 Method of inhibiting cell migration and cell migration inhibitor |